Regulatory Developments June 2019

03a_RegNews_Alternate_770x2953.jpg

News on OMB approval, an FDA workshop on analysis data standards in drug development and regulatory review, and an FDA guidance announcement.

Related Stories

Table of Contents
Regulatory Developments
June 2019